SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is seeing intense community speculation ahead of its upcoming earnings report, with traders debating whether a recent surge in bullish call buying reflects a potential breakout or an orchestrated trap. Investors are heavily focused on the company's growth catalysts, including the removal of day-trading restrictions and a substantial share buyback program, while contending with stagnant price action near key support levels.

Applied Digital Corporation

Applied Digital is experiencing a significant surge in investor interest following the announcement of a massive new multi-billion dollar, 15-year lease agreement with a major hyperscaler for its fourth data center campus. The community is actively discussing the stock's strong execution in the AI infrastructure sector, highlighting a significant backlog of contracted revenue and the potential for a mechanical short squeeze as market sentiment shifts heavily toward a bullish outlook.

Micware Co. Ltd. engages in software development services and innovative IT solutions mainly focused on the automotive and mobility sectors. It operates through the following segments: Software Defined Vehicles (SDV), Location-Based Services (LBS), and Others. The SDV segment relates to the development and sale of software systems designed for SDV, including IVI system software and other mobility-enhancing software products, conducted by its Japanese subsidiaries. The LBS segment covers the development and licensing of in-vehicle navigation software systems, and other geographic data-based services for business-to-business customers, mainly serving end users. The Other segment comprises software development services conducted by overseas subsidiaries designed for SDV, and business-to-consumer mobile app services unrelated to in-vehicle navigation. The company was founded by Kenji Narishima in March 2003 and is headquartered in Kobe, Japan.

Micware Co. Ltd. - ADR

Micware Co. Ltd. (MWC) is experiencing extreme volatility and intense community speculation following a major surge triggered by its recent IPO, with investors heavily debating whether the stock is a high-growth opportunity backed by strategic partnerships with major automakers or a classic pump-and-dump scheme. The community is actively tracking technical support levels, analyzing massive volume spikes, and bracing for continued short-squeeze potential while closely monitoring the stock's wide price swings.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently trending as investors debate the sustainability of its rapid valuation growth amidst a broader semiconductor sector pullback and concerns over insider selling. While community sentiment is split between bullish long-term outlooks on its role in AI infrastructure and skepticism regarding its high price-to-earnings ratio, the stock remains a central focus for traders monitoring institutional flows and technical breakouts.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is facing intense volatility as investors weigh a strong Q1 earnings beat and bullish Q2 delivery guidance against broader market concerns and persistent allegations of share price manipulation. While the community is debating whether the stocks current valuation represents a deep-value buying opportunity following consistent quarterly profitability, many retail investors remain frustrated by the stock's stagnant price action relative to its improving fundamentals.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending following the announcement of a 1 billion dollar government grant to establish a domestic quantum chip foundry, sparking intense discussion among investors regarding the company's long-term leadership in quantum computing. The market sentiment is divided, with some community members viewing the funding as a major validation of IBM's strategic pivot to AI and quantum infrastructure, while others remain skeptical about the stock's recent performance and are debating potential entry points for a long-term hold.

Intuit, Inc. engages in the provision of business and financial management solutions. It operates through the following segments: Small Business and Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business and Self-Employed segment offers QuickBooks financial and business management online services and desktop software, payroll solutions, payment processing solutions, and financing for small businesses. The Consumer segment includes do-it-yourself and assisted TurboTax income tax preparation products and services. The Credit Karma segment serves consumers with a personal finance platform that provides personalized recommendations of credit cards, home, auto and personal loans, and insurance products, and online savings and checking accounts. The ProTax segment refers to the professional accountants in the U.S. and Canada, who are essential to both small business success and tax preparation and filing. The company was founded by Scott D. Cook and Thomas A. Proulx in March 1983 and is headquartered in Mountain View, CA.

Intuit Inc

Intuit shares are facing intense selling pressure following a double-beat earnings report, as investors focus on a 17% workforce reduction and concerns regarding competitive pricing headwinds. The community is sharply divided between those viewing the decline as a major buying opportunity due to strong fundamentals and share buybacks, and those fearing structural disruption from AI alternatives impacting the company's core tax software business.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending following a proposed $100 million equity-backed investment from the U.S. government, sparking intense debate between bulls citing national strategic importance and bears pointing to fundamental concerns regarding low revenue and share dilution. The community remains deeply divided, with active discussion focusing on whether this government endorsement signals a long-term sector mandate or merely a volatile momentum play for speculative traders.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing significant investor attention driven by high trading volume, recent FedRAMP government re-certification, and community optimism surrounding its QNX software integration in emerging fields like physical AI and robotics. Long-term shareholders are actively debating the company's growth potential and its evolving role in mission-critical edge computing, with many viewing the current price action as a key consolidation phase.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is experiencing a surge in community interest driven by a combination of high short interest and a shrinking float fueled by active share repurchases. Investors are actively discussing the potential for a massive short squeeze, comparing the setup to previous market volatility events while emphasizing the company's improving fundamentals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Iran submitted a revised proposal to U.S. negotiators involving sanctions relief and uranium export concessions. However, Trump rejected the proposal over the weekend, calling it “totally unacceptable” on Truth Social.&nbsp;</li><li>Traders are closely watching Tuesday’s inflation print, Trump-Xi talks in Beijing, and geopolitical developments in the Middle East this week.</li><li>AI and memory-chip momentum remained a dominant market theme, with Micron and Everspin among the top-trending stocks on Stocktwits.</li></ul>U.S. stock futures edged lower early Monday as investors weighed the rising crude oil prices amid the latest geopolitical developments in the Middle East. Late Sunday, President Donald Trump rejected Iran’s latest diplomatic peace proposal, calling it “totally unacceptable.”&nbsp;This comes ahead of April CPI inflation data due Tuesday and a closely watched meeting between Trump and Xi Jinping expected later this week in Beijing, their first face-to-face talks in over six months.&nbsp;As of 4:00 a.m. ET on Monday: Nasdaq futures were flat, while S&amp;P 500 and Dow futures declined 0.1%, and Russell 2000 futures edged 0.3% lower.&nbsp;However, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, and the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq-100 Index, has remained ‘bullish’ since last week.Trending Stocks To WatchMicron (MU), Sandisk Corp (SNDK): Memory-chip stocks continued to dominate retail chatter and trade action as the AI infrastructure trade showed little sign of cooling.&nbsp;Everspin Technologies (MRAM)&nbsp;stock surged 35% in early premarket trade. It has more than doubled since April 29,&nbsp; after posting strong quarterly earnings and highlighting a $40 million U.S. defense subcontract.&nbsp;Biotech stocks are garnering attention. Keep an eye on&nbsp;Moderna (MRNA) and Novavax (NVAX).&nbsp;According to reports, a repatriated American from a luxury cruise ship affected by hantavirus tested mildly positive for the Andes strain, while another individual is exhibiting mild symptoms.MoonLake Immunotherapeutics (MLTX)&nbsp;is trending high on Stocktwits after a positive FDA meeting confirmed a "best-in-class" label strategy for its skin drug.&nbsp;ImmunityBio Inc. (IBRX)&nbsp;remained heavily discussed after last week’s 20% rally, even as shares dipped over 1% in early premarket trade. Investors continued to track founder Patrick Soon-Shiong’s comments on international expansion efforts involving Saudi Arabia and Greece.Alpha Tau Medical (DRTS)&nbsp;stock gained 5% in early premarket trading as investors awaited early U.S. clinical results for its brain cancer radiation therapy, due Monday.&nbsp;Lumentum Holdings Inc (LITE) rose 5% in early trade after Nasdaq announced the company will join the Nasdaq-100 index, replacing CoStar Group Inc., effective May 18.AST SpaceMobile Inc. (ASTS) edged higher ahead of earnings due today.Other tickers trending on Stocktwits at the time of writing included Sun Communities (SUI), Lynas Rare Earths (LYSCF), and Rackspace Technologies (RXT).Other Catalysts To WatchOn earnings radar, watch out for quarterly reports from Circle Internet Group Inc (CIRCL), Fox Corporation (FOXA), monday.com Ltd (MNDY), Constellation Energy Corporation (CEG), and Barrick Mining Corporation (GOLD) today. For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Dip As Trump-Iran Tensions Lift Crude Oil Prices: Why MU, MRAM, MLTX, DRTS, ASTS Are In Focus

Data from Stocktwits shows that retail traders’ sentiment has remained ‘bullish’ on SPY and QQQ, following last week’s resilience in tech and AI-linked names. 

Equity

Data from Stocktwits shows that retail traders’ sentiment has remained ‘bullish’ on SPY and QQQ, following last week’s resilience in tech and AI-linked names. 


<ul class="summary-bullets"><li>Dow Jones futures, S&amp;P 500 futures, and Nasdaq 100 futures all declined in Sunday’s overnight session.&nbsp;</li><li>Oil prices climbed, with Brent crude futures exceeding $100 a barrel again.</li><li>On the economic front, markets will be watching the U.S. inflation data slated for release on Tuesday.</li></ul>U.S. stock futures slipped in Sunday’s overnight trading session as Washington’s rejection of the peace proposal from Iran weighed on market sentiment, prolonging the possibility of tight global energy supplies and effective closure of the Strait of Hormuz.Dow Jones futures were 0.41% lower at the time of writing, the S&amp;P 500 futures were down 0.25% and Nasdaq 100 futures declined 0.16% as of 8.53 p.m ET. &nbsp;Meanwhile, oil prices climbed higher on the news.Among ETFs tracking benchmark indexes, the <a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, <a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a>, and the <a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust (DIA)</a> were all edging lower at the time of writing. Meanwhile, retail sentiment on Stocktwits for SPY and QQQ was in the ‘bullish’ territory, while it was ‘neutral’ for DIA.<h2 class="st-heading-2">How Did US Markets Fare?</h2>On Friday, benchmark indexes closed higher, driven by the April jobs report that came in much stronger than expected, with the S&amp;P 500 and Nasdaq Composite rallying to record highs during the session.The Dow Jones Industrial Average closed 0.03% higher, while the S&amp;P 500 and the Nasdaq Composite climbed 0.84% and 1.71%, respectively.<div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Index</td><td>Move</td><td>Close</td></tr><tr><td>Dow Jones Industrial Average</td><td>0.03%</td><td>49,609.16</td></tr><tr><td>S&amp;P 500</td><td>0.84%</td><td>7,398.93</td></tr><tr><td>Nasdaq Composite</td><td>1.71%</td><td>26,247.08</td></tr></tbody></table></figure></div><h2 class="st-heading-2">US Market Drivers</h2>President Donald Trump’s rejection of Iran’s peace proposal sent U.S. stock markets lower over the weekend as markets priced in a longer closure at the Strait of Hormuz that would weigh on global oil prices.According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/livecoverage/iran-war-trump-news/card/iran-s-lengthy-response-to-the-u-s-leaves-some-gaps-jVJkux8wKbRUWK9EOOp9">report</a> from the Wall Street Journal, Iran’s “multipage” response to the latest U.S. proposal to end the war included opening the Strait prior to making nuclear concessions, while also agreeing to export some of its highly enriched uranium to a third country, but stopped short of agreeing to dismantle its existing nuclear sites.However, the president called the proposal “TOTALLY UNACCEPTABLE!” in a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/116552102914488206">post</a> on Truth Social on Sunday. In an earlier <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/116551553302876569">post</a>, Trump accused Iran of “playing games” with the United States and the rest of the world.Trump is reportedly visiting Beijing on Wednesday and is expected to discuss ‌Iran ⁠, among other topics, with Chinese President Xi Jinping.Markets will also be looking for the U.S. inflation data slated for release on Tuesday, which will provide clues on where key interest rates could be headed.<h2 class="st-heading-2">Trending Stocks To Watch</h2>Micron Technology Inc. (MU): The memory stock surged more than 7% in Sunday’s overnight trading, riding the upward momentum after a red-hot week amid growing demand and a shortage of memory chips. MU stock surged to a record high on Friday and has gained a whopping 709% in the past 12 months.Sandisk Corp. (SNDK): The Milpitas, California-based company’s shares also rallied by over 5% in the overnight session heading into Monday on account of the AI memory supercycle and explosive demand for memory chips.Everspin Technologies Inc. (MRAM): Shares of the company surged more than 48% in extended trading hours, on track for their best day since November 2021. Everspin shares have been bolstered higher by strong first-quarter 2026 earnings and a recent $40 million defense subcontract with the U.S. Department of War.MoonLake Immunotherapeutics (MLTX): The company’s stock <a href="https://stocktwits.com/news-articles/markets/equity/mltx-stock-soars-on-fda-backing-clear-street-upside-call/cZX9nINReW3">surged more than 7%</a> in overnight trading after the company said it had conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), in which the apex body aligned on submission plans and the label strategy for its skin drug.<h2 class="st-heading-2">Broader Market Trends</h2>Oil futures climbed higher in Sunday’s overnight session. Brent crude futures expiring in July were up about 3.51%, trading at around $104.85 a barrel, while WTI crude futures expiring in June were 3.89% higher, at $99.13 a barrel at the time of writing.American economist and professor at The Johns Hopkins University, Steve Hanke, warned that oil prices would go higher amid the war. “Once inventories run dry, we will switch from an oil deficit to an oil shortage. Then, prices will SPIKE, AGAIN,” he said in a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/steve_hanke/status/2053497792627397054">post</a> on X.Meanwhile, treasury yields on the benchmark 10-year were at 4.39%, while gold declined to trade around $4,676.59 an ounce.Asian markets were mixed at the open on Monday, with the KOSPI and Nikkei 225 gaining at the time of writing, while the SSE Composite index was largely flat. Australian stocks were lower at the open.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative Image (Photo credit: Getty Images)

Dow, S&P 500, Nasdaq Futures Slip As Trump Calls Iran’s Peace Proposal ‘Totally Unacceptable’ — MU, SNDK, MRAM, MLTX Stocks In Focus

Iran’s “multipage” response reportedly included opening the Hormuz Strait prior to making nuclear concessions, while also agreeing to export some of its highly enriched uranium to a third country.

<ul class="summary-bullets"><li>MoonLake said that the FDA agreed to include results from both the Phase 2 Mira study and Phase 3 Vela trials in the proposed drug label.</li><li>Clear Street maintained a ‘Buy’ rating and $70 price target on MLTX, implying a 310% upside from current levels.</li><li>MoonLake ended the first quarter with $357.9 million in cash and said its current funding runway extends through the end of 2027.</li></ul>Shares of MoonLake Immunotherapeutics, Inc. (MLTX) jumped 7% in overnight trading heading into Monday after the company said that the U.S. Food and Drug Administration (FDA) aligned on its approval filing plans for Sonelokimab, prompting Clear Street to say that the skin therapy could emerge with a “stronger, best-in-class label.”<a href="https://stocktwits.com/symbol/MLTX">MLTX stock</a> snapped two straight weeks of weekly losses and ended 2% higher last week at $17.06.<h2 class="st-heading-2">FDA Backs MoonLake HS Drug Filing</h2>On Sunday, MoonLake said that its final pre-biologics license application (BLA) meeting with the FDA concluded with alignment on certain parts of its application for Sonelokimab in hidradenitis suppurativa (HS), a chronic inflammatory skin disease.MoonLake said that the FDA agreed the results from both its mid-stage Mira study and late-stage Vela trials can be included in the proposed prescribing label for Sonelokimab, boosting the drug’s case for approval in HS. The company also said that the FDA supported including data from the Vela-Teen study, which could allow the treatment to be approved for patients aged 12 and older.&nbsp;The company plans to apply for a Priority Review designation and expects to submit the BLA application by September. Acceptance of the filing, including a decision on Priority Review status, is expected by November. MoonLake also said that the FDA identified no remaining gaps, including manufacturing-related issues, that would prevent the filing.MoonLake said that the proposed label could highlight that 43% of patients in the Mira study achieved a high level of symptom improvement after 12 weeks of treatment, with results outperforming placebo by 29 percentage points. According to the company, the efficacy levels are the strongest reported so far in any well-controlled late-stage clinical study for HS.&nbsp;<h2 class="st-heading-2">Clear Street Sees ‘Best-In-Class’ Label</h2>After the FDA meeting, Clear Street said that MoonLake’s positive pre-application meeting restores the company to its “prior strong positioning” in the HS market. The brokerage said that the FDA’s agreement to include both Mira efficacy data and Vela trial results in the label could result in a “stronger, best-in-class label” for Sonelokimab.Clear Street maintained a ‘Buy’ rating on the stock with a $70 price target, implying&nbsp; an upside of 310% from current levels.&nbsp;<h2 class="st-heading-2">MLTX Cash Runway Extends Into 2027</h2>As of March 31, MoonLake held $357.9 million in cash, cash equivalents and short-term marketable securities,&nbsp;which it expects to fund operations and spending through the end of 2027.The company also retains access to up to $400 million in additional non-dilutive funding through its Hercules Capital debt facility. Research and development expenses totaled $54.5 million during the first quarter, compared with $56 million in the previous quarter. General and administrative expenses rose to $15.5 million from $9.2 million in the prior quarter. MoonLake said the increase was mainly from $4.8 million in accelerated expense recognition related to the voluntary cancellation of unvested stock option awards.<h2 class="st-heading-2">MLTX Reports Strong Long-Term HS Results</h2>The FDA update comes on the heels of encouraging long-term clinical data reported by MoonLake from the Phase 3 Vela-1 and Vela-2 trials in HS. In March, the company said 62% of patients treated with Sonelokimab achieved strong clinical improvement after 40 weeks, while up to 32% saw their skin lesions become nearly clear.Up to 25% of patients achieved inflammatory remission, meaning that the key signs of the disease disappeared completely. Patients also reported improvements in pain, mobility and daily activities such as walking and dressing. According to the company, up to 43% of patients saw reductions in their worst skin pain, while 65% reported improvements in overall quality of life.&nbsp;<h2 class="st-heading-2">More Trial Catalysts Ahead For MLTX</h2>Earlier this year, MoonLake reported positive mid-stage trial results for Sonelokimab in axial spondyloarthritis, an inflammatory condition that affects the spine and joints. The company said that 81% of patients showed improvement within 12 weeks of treatment, with scans and disease markers also indicating reduced inflammation and disease activity.&nbsp;Investors are now watching several upcoming catalysts over the next year, including 52-week data from the Phase 3 Vela studies in the second quarter, results from the Phase 3 Izar-1 trial in psoriatic arthritis and data from the Vela-Teen adolescent study in mid-2026, followed by the BLA submission for HS by the end of September.<h2 class="st-heading-2">How Do Retail Traders Feel About MLTX?</h2>On Stocktwits, retail sentiment for MLTX flipped to ‘bullish’ from ‘bearish’ levels a day ago amid nearly a 400% surge in 24-hour message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/mltx_ss_png_c58df845f7.webp" alt="mltx ss.png" width="969" height="143"><figcaption>MLTX sentiment and message volume as of May 10 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/WallStWolf38/message/652889422">said</a>, “Looking forward to tomorrow! We’ve already been through a lot with this stock. But with this news, the selling pressure should be very low, and it should be possible to break through the USD 20 . After that, it’ll be easier to move higher.”<stembedurl>https://stocktwits.com/WallStWolf38/message/652889422</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/Creisi/message/652878950">said</a>, “There's literally nothing standing in SLK's path to becoming Best in Class across all Inflammatory skin disease indications. Furthermore, we have zero concern of dilution which almost always happens during phase 3 trials nearing drug BLA submission.”<stembedurl>https://stocktwits.com/Creisi/message/652878950</stembedurl>MLTX stock has declined 57% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-flips-tesla-again-in-trillion-dollar-tug-of-war/cZX72SBReWP">Bitcoin Flips Tesla Again In Trillion-Dollar Tug-Of-War&nbsp;</a>

In this photo illustration, a MoonLake Immunotherapeutics company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

MLTX Stock Soars Overnight After FDA Backs Skin Drug Filing — Analyst Sees Over 300% Upside On ‘Best-In-Class’ Label

Shares of MoonLake Immunotherapeutics, Inc. (MLTX) jumped 7% in overnight trading heading into Monday after the company said that the U.S. Food and Drug Administration (FDA) aligned on its approval filing plans 

The company plans to submit its biologics license application (BLA) by September.


MoonLake Immunotherapeutics (MLTX) to Release Earnings on Monday

MoonLake Immunotherapeutics (NASDAQ:MLTX) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-moonlake-immunotherapeutics-stock...

MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Rating of "Hold" from Brokerages

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) has been given an average rating of "Hold" by the sixteen brokerages that are presently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, four have issued a hold r...

Short Interest in MoonLake Immunotherapeutics (NASDAQ:MLTX) Decreases By 14.2%

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) saw a large decrease in short interest in April. As of April 15th, there was short interest totaling 6,654,522 shares, a decrease of 14.2% from the March 31st total of 7,757,169 shares. Based on an average daily trading volume, of...

The CEO of MoonLake Immunotherapeutics Dumped Shares Worth $2.8 Million. Should Investors Avoid the Stock?

Key PointsCEO Jorge Santos da Silva sold 150,000 shares for a transaction value of approximately ~$2.75 million, based on a weighted average sale price of $18.35 per share...

MoonLake Immunotherapeutics (NASDAQ:MLTX) CEO Sells $945,644.79 in Stock

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) CEO Da Silva Jorge Santos sold 51,873 shares of the company's stock in a transaction dated Monday, April 13th. The shares were sold at an...

MoonLake Immunotherapeutics (NASDAQ:MLTX) CEO Da Silva Jorge Santos Sells 98,127 Shares

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) CEO Da Silva Jorge Santos sold 98,127 shares of the stock in a transaction on Friday, April 10th. The stock was sold at an average price of...

MoonLake Immunotherapeutics (NASDAQ:MLTX) CEO Da Silva Jorge Santos Sells 51,873 Shares

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) CEO Da Silva Jorge Santos sold 51,873 shares of MoonLake Immunotherapeutics stock in a transaction that occurred on Monday, April 13th. The...

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.93	--	--	N/A
Q1 '26	-$0.89	-$0.98	-9.89%	MISSED
Q4 '25	-$0.97	--	--	N/A
Q3 '25	-$0.88	-$1.10	-25.17%	MISSED
Q2 '25	-$0.71	-$0.87	-21.82%	MISSED

MLTX
MoonLake Immunotherapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest MLTX News

MLTXMoonLake Immunotherapeutics